Covalon Technologies Ltd. (OTCMKTS:CVALF) Short Interest Update

Covalon Technologies Ltd. (OTCMKTS:CVALF) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 10,100 shares, a growth of 741.7% from the September 15th total of 1,200 shares. Based on an average daily volume of 4,100 shares, the short-interest ratio is currently 2.5 days. Based on an average daily volume of 4,100 shares, the short-interest ratio is currently 2.5 days.

Covalon Technologies Stock Performance

Shares of OTCMKTS CVALF opened at $1.45 on Friday. The company has a market capitalization of $39.76 million, a P/E ratio of 29.01 and a beta of 0.60. Covalon Technologies has a 52-week low of $1.43 and a 52-week high of $3.08. The company’s 50 day moving average price is $1.65 and its 200-day moving average price is $1.74.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.